Antibody Contract Manufacturing Market Expansion Driven by Rising Biologics Demand
The rapid expansion of biologics and targeted therapies has significantly transformed the global pharmaceutical landscape. Increasing reliance on outsourced production models has accelerated growth across antibody contract manufacturing, monoclonal antibody manufacturing, and the biologics contract manufacturing organization (CMO/CDMO) sector. These developments are collectively...
0 Kommentare 0 Geteilt 187 Ansichten 0 Bewertungen